CancerAnswers@Simmons

Lung Cancer

MedBlog Search
AXL Inhibition Restores Response to PD-1 Blockade in STK11/LKB1-mutant NSCLC

Lung Cancer; Research

AXL Inhibition Restores Response to PD-1 Blockade in STK11/LKB1-mutant NSCLC

August 15, 2022

Latest

Cellular Stress Response Promotes Immune Evasion in Lung Cancer

Cellular Stress Response Promotes Immune Evasion in Lung Cancer

October 26, 2020

Novel Drug Combination Fights Resistance to TKI Therapy

Novel Drug Combination Fights Resistance to TKI Therapy

October 26, 2020

Expanding Eligibility Criteria for Cancer Clinical Trials

Expanding Eligibility Criteria for Cancer Clinical Trials

July 20, 2020

All Articles

AXL Inhibition Restores Response to PD-1 Blockade in STK11/LKB1-mutant NSCLC

Lung Cancer; Research

AXL Inhibition Restores Response to PD-1 Blockade in STK11/LKB1-mutant NSCLC

August 15, 2022

Cellular Stress Response Promotes Immune Evasion in Lung Cancer

Lung Cancer; Research

Cellular Stress Response Promotes Immune Evasion in Lung Cancer

  • Kathryn O'Donnell, Ph.D.

October 26, 2020

Novel Drug Combination Fights Resistance to TKI Therapy

Lung Cancer; Research

Novel Drug Combination Fights Resistance to TKI Therapy

  • Amyn Habib, M.D.

October 26, 2020

Expanding Eligibility Criteria for Cancer Clinical Trials

Clinical Trials; Lung Cancer

Expanding Eligibility Criteria for Cancer Clinical Trials

July 20, 2020